Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1230560.RA5V6_1RWNJ2ONIazMqbNwVK5WkuT139ZypvjfTJaZKpU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1230560.RA5V6_1RWNJ2ONIazMqbNwVK5WkuT139ZypvjfTJaZKpU130_assertion type Assertion NP1230560.RA5V6_1RWNJ2ONIazMqbNwVK5WkuT139ZypvjfTJaZKpU130_head.
- NP1230560.RA5V6_1RWNJ2ONIazMqbNwVK5WkuT139ZypvjfTJaZKpU130_assertion description "[Combinatorial targeting on both HER2 and STAT3 may enhance the efficacy of trastuzumab or other HER2-targeting agents in HER2-positive breast and gastric cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1230560.RA5V6_1RWNJ2ONIazMqbNwVK5WkuT139ZypvjfTJaZKpU130_provenance.
- NP1230560.RA5V6_1RWNJ2ONIazMqbNwVK5WkuT139ZypvjfTJaZKpU130_assertion evidence source_evidence_literature NP1230560.RA5V6_1RWNJ2ONIazMqbNwVK5WkuT139ZypvjfTJaZKpU130_provenance.
- NP1230560.RA5V6_1RWNJ2ONIazMqbNwVK5WkuT139ZypvjfTJaZKpU130_assertion SIO_000772 25327561 NP1230560.RA5V6_1RWNJ2ONIazMqbNwVK5WkuT139ZypvjfTJaZKpU130_provenance.
- NP1230560.RA5V6_1RWNJ2ONIazMqbNwVK5WkuT139ZypvjfTJaZKpU130_assertion wasDerivedFrom befree-2016 NP1230560.RA5V6_1RWNJ2ONIazMqbNwVK5WkuT139ZypvjfTJaZKpU130_provenance.
- NP1230560.RA5V6_1RWNJ2ONIazMqbNwVK5WkuT139ZypvjfTJaZKpU130_assertion wasGeneratedBy ECO_0000203 NP1230560.RA5V6_1RWNJ2ONIazMqbNwVK5WkuT139ZypvjfTJaZKpU130_provenance.